Abstract: SA-PO568
Genotype-Phenotype Correlation in Cystinuria
Session Information
- Genetic Diseases: Diagnosis
November 05, 2022 | Location: Exhibit Hall, Orange County Convention Center‚ West Building
Abstract Time: 10:00 AM - 12:00 PM
Category: Genetic Diseases of the Kidneys
- 1102 Genetic Diseases of the Kidneys: Non-Cystic
Authors
- Hossain, Mohammad Dilwar, Mayo Clinic Minnesota, Rochester, Minnesota, United States
- Cogal, Andrea G., Mayo Clinic Minnesota, Rochester, Minnesota, United States
- Porter, Ivan E., Mayo Clinic in Florida, Jacksonville, Florida, United States
- Goldfarb, David S., NYU Langone Health, New York, New York, United States
- Harris, Peter C., Mayo Clinic Minnesota, Rochester, Minnesota, United States
- Lieske, John C., Mayo Clinic Minnesota, Rochester, Minnesota, United States
Background
Cystinuria is an autosomal recessive disorder characterized by impaired proximal renal tubular absorption of cystine. To date no clear genotype-phenotype relationship has been established. This study reviewed genetic and clinical data of a large cohort of suspected cystinuric patients in the Rare Kidney Stone Consortium (RKSC) cystinuria registry.
Methods
Subjects with suspected cystinuria (n=76) were genotyped either by Sanger sequencing or a targeted next generation sequencing (tNGS) panel that includes the 2 cystinuria genes. Clinical data were abstracted from the RKSC cystinuria registry.
Results
Biallelic mutations in SLC3A1 were found in 50 individuals, biallelic mutations in SLC7A9 in 21 individuals, and 1 mutation in each gene in 1 individual. Four individuals had a clear cystinuria phenotype with only a single monoallelic change in SLC3A1 or SLC7A9 detected. Median (IQR) urinary cystine was 706 (460-848) mg/day.
The Table depicts clinical details of participants with disease due to SLC3A1 and SLC7A9 mutations. Urinary cystine excretion and other clinical outcomes did not differ by genotype. Patients with SLC7A9-related disease more commonly had 2 nontruncating mutations and SLC3A1-related disease more commonly had 2 truncating mutations. Multi-exon duplications were common for SLC3A1, found in 14 instances. A total of 16 novel, 32 known SLC3A1 and 12 novel, 12 known SLC7A9 mutations were detected.
Conclusion
The vast majority of cystinuria patients have biallelic disease due to 2 changes in either SLC3A1 or SLC7A9, and not one of each. Cystine excretion and other clinical manifestations did not differ by genotype. Further study is needed to understand genotype-phenotype correlation and the variable outcomes seen in patients with cystinuria.
Funding
- NIDDK Support